Exhibit 99.1
|
Contact:
Lorin Crenshaw 225.388.7322 | |
Albemarle Reports Third Quarter 2012 Results
BATON ROUGE, LA - October 17, 2012 –
Third quarter 2012 highlights:
| • | Quarterly earnings of $99.3 million, or $1.10 per share. |
| • | Net sales of $661 million and EBITDA margin of 25 percent for the quarter, before special items. |
| • | Polymer Solutions delivers 20% margins despite weak electronics and European construction markets. |
| • | Strong Refinery Catalysts volumes partially offset impact of lower metals surcharges. |
| • | Fine Chemistry net sales up 8 percent on strong custom services and performance chemicals growth. |
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| In thousands, except per share amounts |
2012 | 2011 | 2012 | 2011 | ||||||||||||
| Net sales |
$ | 661,226 | $ | 722,977 | $ | 2,057,824 | $ | 2,161,615 | ||||||||
| Segment income |
$ | 145,897 | $ | 186,411 | $ | 495,087 | $ | 538,191 | ||||||||
| Net income attributable to Albemarle Corporation |
$ | 99,261 | $ | 116,098 | $ | 245,036 | $ | 336,837 | ||||||||
| Diluted earnings per share |
$ | 1.10 | $ | 1.28 | $ | 2.72 | $ | 3.66 | ||||||||
| Special items per share |
$ | — | $ | — | $ | 0.82 | $ | — | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted earnings per share excluding special items |
$ | 1.10 | $ | 1.28 | $ | 3.54 | $ | 3.66 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
Albemarle Corporation (NYSE: ALB) reported third quarter 2012 earnings of $99.3 million, or $1.10 per share, compared to third quarter 2011 earnings of $116.1 million, or $1.28 per share. Third quarter 2012 results include $4.1 million, or $0.05 per share, in after-tax charges ($6.5 million before tax) related to a supplemental executive retirement plan (SERP) settlement, and $4.5 million, or $0.05 per share, of net tax benefits related principally to the release of various tax reserves. The Company reported net sales of $661.2 million in the third quarter of 2012 compared to net sales of $723.0 million in the third quarter of 2011, with approximately two-thirds of the change attributable to lower metals surcharges in 2012 in the Catalysts business.
Earnings for the nine months ended September 30, 2012 were $245.0 million, or $2.72 per share, compared to $336.8 million, or $3.66 per share, for the same period in 2011. Excluding the third quarter 2012 special items noted above as well as the second quarter 2012 after-tax special item of $73.6 million related to our exit of the phosphorous flame retardants business, earnings for the nine months ended September 30, 2012 were $318.3 million, or $3.54 per share. Net sales for the nine months ended September 30, 2012 were $2.1 billion compared to $2.2 billion for the same period in 2011.
1
Commenting on results, Luke Kissam, CEO, stated “Given the challenging economic environment, we are pleased with our results. Polymer Solutions faced severe deterioration in the electronics and European construction markets, but its performance was further evidence of the improvements we have made to this business since the 2008/2009 recession. Refinery catalysts volumes were strong in the quarter, but results were negatively impacted by significant reductions in metals surcharges including rare earths. Fine Chemistry delivered 8% revenue growth due to a strong custom services pipeline and late quarter surge in shipments of completion fluids. While I expect fourth quarter to be even more difficult than was the third, I remain confident in our ability to grow our business in 2013.”
Quarterly Segment Results
Catalysts generated net sales of $251.2 million in the third quarter of 2012, a 16 percent decrease from net sales in the third quarter of 2011, due mainly to unfavorable impacts from lower metals surcharges in refinery catalysts and foreign currency, partially offset by higher FCC volumes. Catalysts segment income was $60.7 million in the third quarter of 2012, down 40 percent from third quarter 2011 results of $101.9 million due primarily to unfavorable impacts from metals cost volatility, fixed cost absorption and equity income versus the third quarter of 2011, partially offset by favorable sales volumes and lower spending.
Facing weaker volumes in the electronics and European construction markets, Polymer Solutions reported net sales of $217.0 million in the third quarter of 2012, an 11 percent decrease over net sales in the third quarter of 2011, due mainly to unfavorable pricing and mix, foreign currency impacts and the effects of our phosphorous flame retardants business exit in the second quarter of 2012. Segment income for Polymer Solutions was $43.6 million in the third quarter of 2012, a 20 percent decline from $54.6 million in the third quarter of 2011, due primarily to unfavorable pricing and mix, fixed cost absorption and foreign currency impacts, offset by lower input costs, lower charges attributable to the noncontrolling interest in our Jordanian joint venture and favorable impacts from our exit of the phosphorous business.
Fine Chemistry net sales in the third quarter of 2012 were $193.0 million, an 8 percent increase over net sales in the third quarter of 2011, due mainly to favorable volumes in custom services and performance chemicals, partly offset by unfavorable pricing and foreign currency impacts. Segment income for Fine Chemistry was $41.7 million for the third quarter of 2012, up 39 percent over third quarter 2011 results of $30.0 million, due primarily to favorable volume and input costs, partly offset by unfavorable pricing and foreign currency.
Corporate and Other
Corporate and other expense was $8.0 million for the third quarter of 2012. The decrease from the comparable period in 2011 was due primarily to lower personnel-related costs associated with performance-based incentive compensation levels and related adjustments.
Interest and financing expenses were $7.9 million for the third quarter of 2012 compared to $9.7 million for the third quarter of 2011, with this decrease due primarily to increases in interest capitalized on higher average construction project balances outstanding and lower variable-rate borrowings year-over-year.
2
Our third quarter 2012 effective income tax rate was 21.6 percent versus 25.1 percent in the third quarter of 2011. Excluding special items (see notes to the condensed consolidated financial information), our third quarter 2012 effective income tax rate was 25.9 percent. Our effective tax rate continues to be influenced by the level and geographic mix of income, and benefits from a favorable mix of income in lower tax jurisdictions.
Cash Flow
Our cash flow from operations was approximately $306 million for the nine months ended September 30, 2012, and we had $402.6 million in cash and cash equivalents at September 30, 2012. During the nine months ended September 30, 2012, cash on hand and cash provided by operations funded capital expenditures for plant, machinery and equipment of approximately $218.7 million (which includes approximately $63.4 million in capital expenditures associated with our Jordanian joint venture), long-term debt repayments of $49.2 million, dividends to shareholders of $51.3 million and repurchases of $40.5 million of our common stock.
Outlook
We expect market and economic conditions to remain unstable for the foreseeable future. Polymer Solutions will likely face soft end market demand and low factory operating rates at least through Chinese New Year. While volumes in Performance Chemicals should remain strong, a temporary lull in our Custom Services business will negatively impact Fine Chemistry’s fourth quarter results before continued growth in 2013. Our Catalysts business should finish the year with strong volumes and profitability as it builds toward a solid 2013. While we expect to grow our profitability in all three segments in 2013, if economic uncertainty continues, we are prepared to take appropriate steps to ensure the Company’s financial strength and future growth.
Earnings Call
The Company’s performance for the third quarter ended September 30, 2012 will be discussed on a conference call at 9:00 AM Eastern Daylight time on October 18, 2012. The call can be accessed by dialing 800-295-4740 (International Dial In # 617-614-3925), and entering conference ID 12536010. The Company’s earnings presentation and supporting material can be accessed through Albemarle’s website under Investors at www.albemarle.com.
About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. Albemarle is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry, with Corporate Responsibility Magazine naming Albemarle among its prestigious “100 Best Corporate Citizens” list for 2011. Albemarle employs more than 4,000 people worldwide and serves customers in approximately 100 countries.
3
Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings and other information regarding the Company, its businesses and markets served.
Forward-Looking Statements
Some of the information presented in this press release, including, without limitation, statements with respect to product development, changes in productivity, market trends, price and mix changes, expected growth, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ materially. Factors that could cause actual results to differ from expectations include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy and in our ability to pass through increases; acquisitions and divestitures, and changes in performance of acquired companies; fluctuations in foreign currencies; changes in laws and government regulation impacting our operations or our products; the occurrence of claims or litigation; the occurrence of natural disasters; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest, including terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings; changes in monetary policies or inflation or interest rates, which may impact our ability to raise capital or increase our cost of funds, the performance of our pension fund investments and our pension expense and funding obligations; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement and other risks; decisions we may make in the future; and the other factors detailed from time to time in the reports we file with the SEC, including those described under “Risk Factors” in our Annual Report on Form 10-K and our 2012 Quarterly Reports on Form 10-Q.
4
Albemarle Corporation and Subsidiaries
Consolidated Statements of Income
(In Thousands Except Per Share Amounts) (Unaudited)
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Net sales |
$ | 661,226 | $ | 722,977 | $ | 2,057,824 | $ | 2,161,615 | ||||||||
| Cost of goods sold |
446,469 | 464,965 | 1,352,495 | 1,418,638 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Gross profit |
214,757 | 258,012 | 705,329 | 742,977 | ||||||||||||
| Selling, general and administrative expenses (a) |
59,982 | 77,169 | 215,298 | 233,115 | ||||||||||||
| Research and development expenses |
19,831 | 20,534 | 59,791 | 58,096 | ||||||||||||
| Restructuring and other charges (b) |
6,508 | — | 101,211 | — | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Operating profit |
128,436 | 160,309 | 329,029 | 451,766 | ||||||||||||
| Interest and financing expenses |
(7,914 | ) | (9,710 | ) | (25,134 | ) | (28,576 | ) | ||||||||
| Other income, net |
2,370 | 956 | 1,564 | 534 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income before income taxes and equity in net income of unconsolidated investments |
122,892 | 151,555 | 305,459 | 423,724 | ||||||||||||
| Income tax expense (c) |
26,591 | 38,097 | 76,804 | 100,423 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income before equity in net income of unconsolidated investments |
96,301 | 113,458 | 228,655 | 323,301 | ||||||||||||
| Equity in net income of unconsolidated investments (net of tax) |
7,935 | 9,500 | 29,233 | 37,118 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
104,236 | 122,958 | 257,888 | 360,419 | ||||||||||||
| Net income attributable to noncontrolling interests |
(4,975 | ) | (6,860 | ) | (12,852 | ) | (23,582 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income attributable to Albemarle Corporation |
$ | 99,261 | $ | 116,098 | $ | 245,036 | $ | 336,837 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Basic earnings per share |
$ | 1.11 | $ | 1.29 | $ | 2.75 | $ | 3.70 | ||||||||
| Diluted earnings per share |
$ | 1.10 | $ | 1.28 | $ | 2.72 | $ | 3.66 | ||||||||
| Weighted-average common shares outstanding – basic |
89,327 | 89,935 | 89,246 | 91,094 | ||||||||||||
| Weighted-average common shares outstanding – diluted |
89,879 | 90,958 | 89,959 | 92,090 | ||||||||||||
See accompanying notes to the condensed consolidated financial information.
5
Albemarle Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(In Thousands) (Unaudited)
| September 30, 2012 |
December 31, 2011 |
|||||||
| ASSETS |
||||||||
| Cash and cash equivalents |
$ | 402,642 | $ | 469,416 | ||||
| Other current assets |
984,210 | 886,204 | ||||||
|
|
|
|
|
|||||
| Total current assets |
1,386,852 | 1,355,620 | ||||||
|
|
|
|
|
|||||
| Property, plant and equipment |
2,830,268 | 2,619,428 | ||||||
| Less accumulated depreciation and amortization |
1,577,129 | 1,489,948 | ||||||
|
|
|
|
|
|||||
| Net property, plant and equipment |
1,253,139 | 1,129,480 | ||||||
| Other assets and intangibles |
722,664 | 718,724 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 3,362,655 | $ | 3,203,824 | ||||
|
|
|
|
|
|||||
| LIABILITIES AND EQUITY |
||||||||
| Current portion of long-term debt |
$ | 12,572 | $ | 14,416 | ||||
| Other current liabilities |
369,940 | 386,762 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
382,512 | 401,178 | ||||||
|
|
|
|
|
|||||
| Long-term debt |
701,162 | 749,257 | ||||||
| Other noncurrent liabilities |
278,430 | 296,659 | ||||||
| Deferred income taxes |
99,268 | 77,903 | ||||||
| Albemarle Corporation shareholders’ equity |
1,808,354 | 1,591,277 | ||||||
| Noncontrolling interests |
92,929 | 87,550 | ||||||
|
|
|
|
|
|||||
| Total liabilities & equity |
$ | 3,362,655 | $ | 3,203,824 | ||||
|
|
|
|
|
|||||
See accompanying notes to the condensed consolidated financial information.
6
Albemarle Corporation and Subsidiaries
Selected Consolidated Cash Flow Data
(In Thousands) (Unaudited)
| Nine Months Ended September 30, |
||||||||
| 2012 | 2011 | |||||||
| Cash and cash equivalents at beginning of year |
$ | 469,416 | $ | 529,650 | ||||
| Cash and cash equivalents at end of period |
$ | 402,642 | $ | 481,258 | ||||
| Sources of cash and cash equivalents: |
||||||||
| Net income |
257,888 | 360,419 | ||||||
| Proceeds from borrowings |
— | 132,859 | ||||||
| Proceeds from exercise of stock options |
19,977 | 1,103 | ||||||
| Uses of cash and cash equivalents: |
||||||||
| Capital expenditures |
(218,708 | ) | (127,111 | ) | ||||
| Repurchases of common stock |
(40,470 | ) | (178,132 | ) | ||||
| Repayments of long-term debt |
(49,243 | ) | (105,076 | ) | ||||
| Dividends paid to shareholders |
(51,287 | ) | (43,098 | ) | ||||
| Pension and postretirement contributions |
(19,705 | ) | (57,555 | ) | ||||
| Investments in equity and other corporate investments |
— | (10,868 | ) | |||||
| Long-term advances to joint venture |
(22,500 | ) | — | |||||
| Non-cash items: |
||||||||
| Depreciation and amortization |
74,428 | 71,926 | ||||||
| Restructuring and other charges (b) |
101,211 | — | ||||||
| Equity in net income of unconsolidated investments |
(29,233 | ) | (37,118 | ) | ||||
See accompanying notes to the condensed consolidated financial information.
7
Albemarle Corporation and Subsidiaries
Consolidated Summary of Segment Results
(In Thousands) (Unaudited)
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Net sales: |
||||||||||||||||
| Polymer Solutions |
$ | 216,992 | $ | 243,931 | $ | 692,139 | $ | 792,604 | ||||||||
| Catalysts |
251,201 | 299,531 | 773,867 | 827,339 | ||||||||||||
| Fine Chemistry |
193,033 | 179,515 | 591,818 | 541,672 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total net sales |
$ | 661,226 | $ | 722,977 | $ | 2,057,824 | $ | 2,161,615 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Segment operating profit: |
||||||||||||||||
| Polymer Solutions |
$ | 42,964 | $ | 55,219 | $ | 157,487 | $ | 203,900 | ||||||||
| Catalysts |
53,937 | 93,682 | 185,656 | 209,251 | ||||||||||||
| Fine Chemistry |
46,036 | 34,793 | 135,543 | 111,387 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total segment operating profit |
142,937 | 183,694 | 478,686 | 524,538 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Equity in net income of unconsolidated investments: |
||||||||||||||||
| Polymer Solutions |
1,199 | 1,357 | 4,957 | 6,496 | ||||||||||||
| Catalysts |
6,736 | 8,170 | 24,276 | 30,796 | ||||||||||||
| Fine Chemistry |
— | — | — | — | ||||||||||||
| Corporate & other |
— | (27 | ) | — | (174 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total equity in net income of unconsolidated investments |
7,935 | 9,500 | 29,233 | 37,118 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net (income) loss attributable to noncontrolling interests: |
||||||||||||||||
| Polymer Solutions |
(602 | ) | (2,021 | ) | (1,255 | ) | (9,200 | ) | ||||||||
| Catalysts |
— | — | — | — | ||||||||||||
| Fine Chemistry |
(4,373 | ) | (4,789 | ) | (11,577 | ) | (14,439 | ) | ||||||||
| Corporate & other |
— | (50 | ) | (20 | ) | 57 | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total net income attributable to noncontrolling interests |
(4,975 | ) | (6,860 | ) | (12,852 | ) | (23,582 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Segment income: |
||||||||||||||||
| Polymer Solutions |
43,561 | 54,555 | 161,189 | 201,196 | ||||||||||||
| Catalysts |
60,673 | 101,852 | 209,932 | 240,047 | ||||||||||||
| Fine Chemistry |
41,663 | 30,004 | 123,966 | 96,948 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total segment income |
145,897 | 186,411 | 495,087 | 538,191 | ||||||||||||
| Corporate & other |
(7,993 | ) | (23,462 | ) | (48,466 | ) | (72,889 | ) | ||||||||
| Restructuring and other charges (b) |
(6,508 | ) | — | (101,211 | ) | — | ||||||||||
| Interest and financing expenses |
(7,914 | ) | (9,710 | ) | (25,134 | ) | (28,576 | ) | ||||||||
| Other income, net |
2,370 | 956 | 1,564 | 534 | ||||||||||||
| Income tax expense (c) |
(26,591 | ) | (38,097 | ) | (76,804 | ) | (100,423 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income attributable to Albemarle Corporation |
$ | 99,261 | $ | 116,098 | $ | 245,036 | $ | 336,837 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
See accompanying notes to the condensed consolidated financial information.
8
Notes to the Condensed Consolidated Financial Information
| (a) | The nine month period ended September 30, 2012 includes a gain of $8.1 million ($5.1 million after tax, or $0.06 per share) resulting from proceeds received in connection with the settlement of litigation (net of related legal fees). The nine month period ended September 30, 2012 also includes an $8 million charitable contribution ($5.1 million after tax, or $0.06 per share) to the Albemarle Foundation. |
| (b) | The three-month and nine-month periods ended September 30, 2012 include a settlement charge of $6.5 million ($4.1 million after income taxes, or $0.05 per share) associated with our SERP in connection with the retirement of our former CEO and executive chairman. The nine month period ended September 30, 2012 also includes charges amounting to $94.7 million ($73.6 million after income taxes, or $0.82 per share) in connection with our exit of the phosphorous flame retardants business |
| (c) | The three-month and nine-month periods ended September 30, 2012 include $4.5 million, or $0.05 per share, of net tax benefits related principally to the release of various tax reserves. |
Additional Information
It should be noted that net income attributable to Albemarle Corporation (“earnings”), earnings per share and effective income tax rates which exclude special items, as well as presentations of segment operating profit, segment income, EBITDA, EBITDA excluding special items, EBITDA margin and EBITDA margin excluding special items are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance.
A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under “Non-GAAP Reconciliations” under “Financials.” Also, see attached for a supplemental reconciliation of our segment operating profit and segment income amounts to GAAP Operating profit and GAAP Net income attributable to Albemarle Corporation, respectively, as well as for a supplemental reconciliation of our GAAP Net income attributable to Albemarle Corporation to EBITDA and EBITDA excluding special items.
9
ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliation
(In Thousands)
(Unaudited)
Our segment information includes measures we refer to as “segment operating profit,” “segment income,” “EBITDA” and “EBITDA excluding special items,” which are financial measures that are not required by, or presented in accordance with, GAAP. The Company has reported segment operating profit, segment income, EBITDA and EBITDA excluding special items because management believes that these financial measures provide transparency to investors and enable period-to-period comparability of financial performance. Segment operating profit, segment income, EBITDA and EBITDA excluding special items should not be considered as alternatives to operating profit or net income attributable to Albemarle Corporation, as determined in accordance with GAAP.
See below for a reconciliation of segment operating profit and segment income, the non-GAAP financial measures, to Operating profit and Net income attributable to Albemarle Corporation, respectively, the most directly comparable financial measures calculated and reported in accordance with GAAP.
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Total segment operating profit |
$ | 142,937 | $ | 183,694 | $ | 478,686 | $ | 524,538 | ||||||||
| Corporate & other * |
(7,993 | ) | (23,385 | ) | (48,446 | ) | (72,772 | ) | ||||||||
| Restructuring and other charges |
(6,508 | ) | — | (101,211 | ) | — | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| GAAP Operating profit |
$ | 128,436 | $ | 160,309 | $ | 329,029 | $ | 451,766 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total segment income |
$ | 145,897 | $ | 186,411 | $ | 495,087 | $ | 538,191 | ||||||||
| Corporate & other |
(7,993 | ) | (23,462 | ) | (48,466 | ) | (72,889 | ) | ||||||||
| Restructuring and other charges |
(6,508 | ) | — | (101,211 | ) | — | ||||||||||
| Interest and financing expenses |
(7,914 | ) | (9,710 | ) | (25,134 | ) | (28,576 | ) | ||||||||
| Other income, net |
2,370 | 956 | 1,564 | 534 | ||||||||||||
| Income tax expense |
(26,591 | ) | (38,097 | ) | (76,804 | ) | (100,423 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| GAAP Net income attributable to Albemarle Corporation |
$ | 99,261 | $ | 116,098 | $ | 245,036 | $ | 336,837 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| * | Excludes corporate equity income and noncontrolling interest adjustments of $(77) for the three-month period ended September 30, 2011, and $(20) and $(117) for the nine-month periods ended September 30, 2012 and 2011, respectively. |
10
See below for a reconciliation of net income attributable to Albemarle Corporation excluding special items, EBITDA and EBITDA excluding special items, the non-GAAP financial measures, from net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. EBITDA is defined as Net income attributable to Albemarle Corporation before interest and financing expenses, income taxes, depreciation and amortization. EBITDA excluding special items is defined as EBITDA before the special items as listed below.
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Net income attributable to Albemarle Corporation |
$ | 99,261 | $ | 116,098 | $ | 245,036 | $ | 336,837 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Add: |
||||||||||||||||
| Restructuring and other charges, net of tax |
4,114 | — | 77,704 | — | ||||||||||||
| Less: |
||||||||||||||||
| Discrete net tax benefits |
(4,490 | ) | — | (4,490 | ) | — | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income attributable to Albemarle Corporation excluding special items |
$ | 98,885 | $ | 116,098 | $ | 318,250 | $ | 336,837 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income attributable to Albemarle Corporation |
$ | 99,261 | $ | 116,098 | $ | 245,036 | $ | 336,837 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Add: |
||||||||||||||||
| Interest and financing expenses |
7,914 | 9,710 | 25,134 | 28,576 | ||||||||||||
| Income tax expense |
26,591 | 38,097 | 76,804 | 100,423 | ||||||||||||
| Depreciation and amortization |
24,979 | 24,616 | 74,428 | 71,926 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| EBITDA |
158,745 | 188,521 | 421,402 | 537,762 | ||||||||||||
| Restructuring and other charges |
6,508 | — | 101,211 | — | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| EBITDA excluding special items |
$ | 165,253 | $ | 188,521 | $ | 522,613 | $ | 537,762 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net sales |
$ | 661,226 | $ | 722,977 | $ | 2,057,824 | $ | 2,161,615 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| EBITDA Margin |
24.0 | % | 26.1 | % | 20.5 | % | 24.9 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| EBITDA Margin excluding special items |
25.0 | % | 26.1 | % | 25.4 | % | 24.9 | % | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
11